BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23064044)

  • 1. Validation of high-resolution DNA melting analysis for mutation scanning of the CDKL5 gene: identification of novel mutations.
    Raymond L; Diebold B; Leroux C; Maurey H; Drouin-Garraud V; Delahaye A; Dulac O; Metreau J; Melikishvili G; Toutain A; Rivier F; Bahi-Buisson N; Bienvenu T
    Gene; 2013 Jan; 512(1):70-5. PubMed ID: 23064044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key clinical features to identify girls with CDKL5 mutations.
    Bahi-Buisson N; Nectoux J; Rosas-Vargas H; Milh M; Boddaert N; Girard B; Cances C; Ville D; Afenjar A; Rio M; Héron D; N'guyen Morel MA; Arzimanoglou A; Philippe C; Jonveaux P; Chelly J; Bienvenu T
    Brain; 2008 Oct; 131(Pt 10):2647-61. PubMed ID: 18790821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model.
    Chou LS; Lyon E; Wittwer CT
    Am J Clin Pathol; 2005 Sep; 124(3):330-8. PubMed ID: 16191501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy.
    Rosas-Vargas H; Bahi-Buisson N; Philippe C; Nectoux J; Girard B; N'Guyen Morel MA; Gitiaux C; Lazaro L; Odent S; Jonveaux P; Chelly J; Bienvenu T
    J Med Genet; 2008 Mar; 45(3):172-8. PubMed ID: 17993579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational spectrum of CDKL5 in early-onset encephalopathies: a study of a large collection of French patients and review of the literature.
    Nemos C; Lambert L; Giuliano F; Doray B; Roubertie A; Goldenberg A; Delobel B; Layet V; N'guyen MA; Saunier A; Verneau F; Jonveaux P; Philippe C
    Clin Genet; 2009 Oct; 76(4):357-71. PubMed ID: 19793311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDKL5 and ARX mutations are not responsible for early onset severe myoclonic epilepsy in infancy.
    Nabbout R; Depienne C; Chipaux M; Girard B; Souville I; Trouillard O; Dulac O; Chelly J; Afenjar A; Héron D; Leguern E; Beldjord C; Bienvenu T; Bahi-Buisson N
    Epilepsy Res; 2009 Nov; 87(1):25-30. PubMed ID: 19734009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early onset seizures and Rett-like features associated with mutations in CDKL5.
    Evans JC; Archer HL; Colley JP; Ravn K; Nielsen JB; Kerr A; Williams E; Christodoulou J; Gécz J; Jardine PE; Wright MJ; Pilz DT; Lazarou L; Cooper DN; Sampson JR; Butler R; Whatley SD; Clarke AJ
    Eur J Hum Genet; 2005 Oct; 13(10):1113-20. PubMed ID: 16015284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer.
    Fukui T; Ohe Y; Tsuta K; Furuta K; Sakamoto H; Takano T; Nokihara H; Yamamoto N; Sekine I; Kunitoh H; Asamura H; Tsuchida T; Kaneko M; Kusumoto M; Yamamoto S; Yoshida T; Tamura T
    Clin Cancer Res; 2008 Aug; 14(15):4751-7. PubMed ID: 18676744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Historic, clinical, and prognostic features of epileptic encephalopathies caused by CDKL5 mutations.
    Moseley BD; Dhamija R; Wirrell EC; Nickels KC
    Pediatr Neurol; 2012 Feb; 46(2):101-5. PubMed ID: 22264704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis.
    Lin J; Qian J; Yao DM; Li Y; Yang J; Chen Q; Chai HY; Xiao GF; Xu WR
    Clin Biochem; 2011 Jul; 44(10-11):779-83. PubMed ID: 21539821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
    Shabbeer J; Robinson M; Desnick RJ
    Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizures and electroencephalographic findings in CDKL5 mutations: case report and review.
    Grosso S; Brogna A; Bazzotti S; Renieri A; Morgese G; Balestri P
    Brain Dev; 2007 May; 29(4):239-42. PubMed ID: 17049193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKL5 alterations lead to early epileptic encephalopathy in both genders.
    Liang JS; Shimojima K; Takayama R; Natsume J; Shichiji M; Hirasawa K; Imai K; Okanishi T; Mizuno S; Okumura A; Sugawara M; Ito T; Ikeda H; Takahashi Y; Oguni H; Imai K; Osawa M; Yamamoto T
    Epilepsia; 2011 Oct; 52(10):1835-42. PubMed ID: 21770923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The three stages of epilepsy in patients with CDKL5 mutations.
    Bahi-Buisson N; Kaminska A; Boddaert N; Rio M; Afenjar A; Gérard M; Giuliano F; Motte J; Héron D; Morel MA; Plouin P; Richelme C; des Portes V; Dulac O; Philippe C; Chiron C; Nabbout R; Bienvenu T
    Epilepsia; 2008 Jun; 49(6):1027-37. PubMed ID: 18266744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal origin of a novel C-terminal truncation mutation in CDKL5 causing a severe atypical form of Rett syndrome.
    Nectoux J; Heron D; Tallot M; Chelly J; Bienvenu T
    Clin Genet; 2006 Jul; 70(1):29-33. PubMed ID: 16813600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations of dystrophin gene in DMD patients detected by rapid scanning in biplex exons DHPLC analysis.
    Muscarella LA; Piemontese MR; Barbano R; Fazio A; Guarnieri V; Quattrone A; Zelante L
    Biomol Eng; 2007 Jun; 24(2):231-6. PubMed ID: 17145200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
    Cohen V; Agulnik JS; Jarry J; Batist G; Small D; Kreisman H; Tejada NA; Miller WH; Chong G
    Cancer; 2006 Dec; 107(12):2858-65. PubMed ID: 17096434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy.
    Elia M; Falco M; Ferri R; Spalletta A; Bottitta M; Calabrese G; Carotenuto M; Musumeci SA; Lo Giudice M; Fichera M
    Neurology; 2008 Sep; 71(13):997-9. PubMed ID: 18809835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotype of 5 females with a CDKL5 mutation.
    Stalpers XL; Spruijt L; Yntema HG; Verrips A
    J Child Neurol; 2012 Jan; 27(1):90-3. PubMed ID: 21765152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.